Valuation: Ainos, Inc.

Market Cap 90.82L 82.3L 76.13L 68.69L 1.29Cr 86Cr 1.34Cr 9.14Cr 3.63Cr 46Cr 3.41Cr 3.34Cr 145.21Cr P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 1.97Cr 1.78Cr 1.65Cr 1.49Cr 2.8Cr 185.42Cr 2.9Cr 20Cr 7.85Cr 99Cr 7.38Cr 7.22Cr 314.4Cr EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
35.12%
Yield 2024 *
-
Yield 2025 -
1 day-1.63%
1 week+125.83%
Current month+115.56%
1 month+46.68%
3 months-4.58%
6 months-18.36%
Current year-17.38%
1 week 0.43
Extreme 0.434
2
1 month 0.43
Extreme 0.434
2
Current year 0.43
Extreme 0.434
3.88
1 year 0.43
Extreme 0.434
3.88
3 years 0.43
Extreme 0.434
21.45
5 years 0.43
Extreme 0.434
450
10 years 0.43
Extreme 0.434
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 49 15/04/2021
Director/Board Member 54 15/04/2021
Director/Board Member 42 15/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
03/06/26 Buy

Director

2,000 0.0286%
28/05/26 Buy

Director

250 0.0036%
27/05/26 Buy

Director

2,000 0.0286%
Change 5-day change 1-year change 3-year change Capi.($)
-9.76%+125.83%-38.55%-91.53% 90.82L
-0.87%-3.19%+23.18%+47.87% 26TCr
-0.65%-1.15%+5.44%+11.15% 16TCr
-0.75%-3.55%-18.75%+46.14% 15TCr
+0.24%+1.67%-56.02%-18.14% 6.43TCr
+0.42%+2.72%+26.93%+59.42% 6.16TCr
+0.38%+2.34%+5.72%-10.64% 5.39TCr
-1.05%-3.87%+19.85%+51.68% 4.9TCr
-0.23%-1.94%+8.47%+71.38% 4.88TCr
-1.37%-3.92%+21.17%+72.05% 4.52TCr
Average -0.48%+8.66%-0.26%+23.94% 9TCr
Weighted average by Cap. -0.48%+0.81%+5.26%+36.15%

Financials

2024 2025
Net sales 20.73T 18.78T 17.37T 15.68T 29.54T 19.55L 30.58T 2L 82.76T 10.44L 77.79T 76.14T 33.14L 1L 1L 1L 93.89T 2L 1.17Cr 2L 12.5L 5L 62.53L 5L 5L 1.99Cr
Net income -1.49Cr -1.35Cr -1.25Cr -1.12Cr -2.12Cr -140.14Cr -2.19Cr -15Cr -5.93Cr -75Cr -5.58Cr -5.46Cr -237.63Cr -1.48Cr -1.34Cr -1.24Cr -1.12Cr -2.11Cr -139.27Cr -2.18Cr -15Cr -5.9Cr -74Cr -5.54Cr -5.43Cr -236.16Cr
Net Debt 81.07L 73.47L 67.95L 61.31L 1.16Cr 76Cr 1.2Cr 8.16Cr 3.24Cr 41Cr 3.04Cr 2.98Cr 129.62Cr 1.06Cr 95.9L 88.7L 80.03L 1.51Cr 100Cr 1.56Cr 11Cr 4.23Cr 53Cr 3.97Cr 3.89Cr 169.19Cr
Projected Income Statement - Annual - Ainos, Inc.
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
16/26/16 $1.150 -6.50% 2,07,71,923
13/26/13 $1.230 +16.04% 46,86,687
12/26/12 $1.060 +118.65% 8,07,05,694
11/26/11 $0.4848 +3.30% 70,029
10/26/10 $0.4693 -21.78% 58,107
  1. Stock Market
  2. Stocks
  3. AIMD Stock